Mobile Health Apps Trends

Mobile Health App Trends in H1 2026: Growth Outpaces Clinical Maturity

The mobile health app landscape is expanding, but space growth is moving faster…


Healthcare and Pharma Trends H1 2026

Healthcare and Pharma Trends H1 2026: Innovation Shifts Toward Real-World Delivery

Healthcare and pharma trends in H1 2026 point to a common strategic change:…


Lucid Diligence Brief - Tech

Excalipoint Therapeutics and DP Technology Partnership | Lucid Diligence Brief

Excalipoint Therapeutics and DP Technology have partnered to develop an agentic…


Public Health Strategic Roundup

Public Health Strategic Roundup | June 11–July 15, 2026

Key Strategic Developments Shaping Public Health Coverage: June 11–July 15,…


ISTH 2026 preview highlighting competitive developments in hemophilia, von Willebrand disease, anticoagulation and AI diagnostics.

ISTH 2026 Preview: Hemophilia, VWD and Anticoagulation Market Trends

ISTH 2026 at a glance ISTH 2026 brings emerging competitive dynamics into focus…


Lucid Diligence Brief - Tech

DermaSensor AI dermatology devices | Lucid Diligence Brief

AI dermatology devices are advancing beyond validation studies as DermaSensor…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Unio Health Partners and Thesis Care partnership

Lucid Diligence Brief: Unio Health Partners and Thesis Care’s AI clinical teams…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Insilico and Human Longevity collaboration

Lucid Diligence Brief: Insilico Medicine and Human Longevity collaborate on AI…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: NeuroXT and BIDMC Expand Alzheimer’s AI Imaging Collaboration

Lucid Diligence Brief: NeuroXT and BIDMC expand their Alzheimer’s AI imaging…


Artificial_Intelligence

AI in Healthcare and Digital Health Today—May 26, 2026

This week’s AI in Healthcare and Digital Health update highlights…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Plus Therapeutics and Ephemeral AI Partnership in CNS Oncology

Lucid Diligence Brief: Plus Therapeutics and Ephemeral AI partnership raises…


Privacy Preference Center